Sarkar vs. John Doe: What happened at this week’s hearing involving PubPeer

Fazlul Sarkar
Fazlul Sarkar

On Tuesday, lawyers representing both sides of the ongoing suit filed by a scientist against PubPeer commenters appeared in court, alleging their criticisms of his work cost him a new job at the University of Mississippi.

In the case described as “FAZLUL SARKAR V JOHN DOE,” lawyers representing PubPeer, Sarkar, and the anonymous commenter at the heart of the case spoke before two judges (one was absent). As the case now stands, a judge has ruled that all but one of the commenters can remain anonymous, and PubPeer has filed an appeal, earning the support of the American Civil Liberties Union (ACLU), as well as Google and Twitter.

According to one of the attorneys representing PubPeer, Alex Abdo at the ACLU, things proceeded as expected. Their main argument, he said, was: Continue reading Sarkar vs. John Doe: What happened at this week’s hearing involving PubPeer

Physics journal retracts paper without alerting author

annals-of-physics

An Elsevier journal has angered an author by removing his study without telling him.

After spending months asking the journal why it removed the paper — about a heavily debated theorem in physics — and getting no response, the author threatened to seek damages from the journal and publisher for “permanently stigmatizing” his work. Yesterday, an Elsevier representative told the author what happened: Experts told the journal the paper had a major mistake, so the journal decided to withdraw the study, but failed to tell the author due to an “internal error.”

That explanation didn’t satisfy study author Joy Christian, scientific director of the Einstein Centre for Local-Realistic Physics in Oxford, UK, who has demanded the journal either republish the article or remove it and return the copyright to him, or he will pursue legal action.

Here’s the cryptic publisher’s note for “Local causality in a Friedmann–Robertson–Walker spacetime:” Continue reading Physics journal retracts paper without alerting author

Scientist faces off with PubPeer commenters in new hearing next week

Fazlul Sarkar
Fazlul Sarkar

On Tuesday, a Detroit courtroom will hear arguments in a case against PubPeer commenters, in which a scientist alleges their criticisms of his work cost him a new job at the University of Mississippi.

This isn’t the first time both sides have met in court: Fazlul Sarkar first gained attention in 2014 when he sued anonymous commenters of PubPeer for defamation; in 2015, a judge ruled that all but one of the commenters should be allowed to remain anonymous. PubPeer has filed an appeal, earning the support of the American Civil Liberties Union (ACLU), as well as Google and Twitter.

Meanwhile, Sarkar has earned 18 retractions, many citing an institutional investigation at Wayne State University.

We spoke with attorney Alex Abdo at the ACLU, who is representing the PubPeer commenters in this case, about what to expect at next week’s hearing.

Retraction Watch: What will happen at this hearing? Continue reading Scientist faces off with PubPeer commenters in new hearing next week

1st retraction for researcher who lost whistleblower lawsuit

microvascular-research

A researcher who was dismissed from Wayne State University — then lost a whistleblower lawsuit against it — has logged his first retraction.

In 2012, after Christian Kreipke was dismissed from Wayne State, he filed a lawsuit, alleging that the institution had defrauded the U.S. government of $169 million in research funding. A judge dismissed the case in 2014, noting Kreipke cited “no specific facts,” and as a public university, Wayne State had immunity as an “arm of the state.”

The university’s president has said Kreipke was fired due to misconduct — not his whistleblowing, according to Courthouse News Service

Now, a retraction has appeared for Kreipke in Microvascular Research, citing discrepancies between the original data and what was reported in the paper. 

Here’s the retraction notice: Continue reading 1st retraction for researcher who lost whistleblower lawsuit

Doctor who participated in fake chocolate study fined for violating code of conduct

Source: AKA
Source: AKA

A German district attorney has fined a doctor who participated in a bogus study showing chocolate helps weight loss, designed to illustrate how shady science can make the news, arguing it was unethical to ask people to participate unknowingly in such a scam.

As soon as the study was published, critics raised questions over whether it was appropriate to include volunteers in a bogus clinical trial, which included giving blood. Recently, a German district attorney for professional conduct of physicians ruled that it was not.

In an anonymized version of a decision from the district attorney – who investigates on possible violations of the physicians’ professional law – he fined the doctor who participated in a bogus study about the health benefits of chocolate 500 Euros for not obtaining proper consent from the people who volunteered to participate, and for not involving an ethics committee. Continue reading Doctor who participated in fake chocolate study fined for violating code of conduct

Correction cites “unreliable” data in paper by researchers at center of Duke lawsuit

Journal of Biological ChemistryA researcher charged with embezzlement — and now the subject of a multi-million dollar lawsuit — has earned another correction, again citing “unreliable” data.

But this doesn’t appear to be a run-of-the-mill correction notice.

Firstly, it affects a paper co-authored by Erin Potts-Kant and William Foster, former Duke employees now being sued (along with Duke) for including fraudulent data in $200 million worth of federal grants. Secondly, the notice in the Journal of Biological Chemistry is four paragraphs long, and includes six figures — it would normally be considered a “mega-correction.” But lastly, even though the notice is labeled a “correction,” it’s not immediately apparent which aspects of the paper are being changed.

Here are some excerpts from the newest notice: Continue reading Correction cites “unreliable” data in paper by researchers at center of Duke lawsuit

Researcher who sued to stop retractions earns his 8th

Mario Saad
Mario Saad

Mario Saad, a diabetes researcher who once sued to stop a publisher from retracting his papers, has just received his eighth retraction.

Critical Care has retracted a 2012 paper about treating sepsis, citing extensive similarities between figures within the paper and 10 others.

Here’s the full notice for “Diacerhein attenuates the inflammatory response and improves survival in a model of severe sepsis:” Continue reading Researcher who sued to stop retractions earns his 8th

Columbia has settled a fraud case for $9.5M. Here’s why that’s important.

John Thomas
John Thomas

This summer, Columbia University signed a settlement agreement with the U.S. government over a case filed under the False Claims Act (FCA), which enables whistleblowers to sue institutions on behalf of the government. Although this may seem like one of the many legal issues facing academic science recently, this case merits a closer look, says John R. Thomas, Jr., an attorney with Gentry Locke who represents whistleblowers in a variety of FCA cases – including a potentially landmark case against Duke University that we covered for Science. Thomas – who also authored a three-part Retraction Watch primer on how to file an FCA suit (“So You Want to Be a Whistleblower?” Part One, Part Two, Part Three) – tells us what we need to know about this latest FCA verdict.

As readers of Retraction Watch are unfortunately well aware, dishonesty in research comes in many forms. While we often focus on dishonesty in research itself, scientists and institutions may also defraud the government through a variety of administrative avenues, such as effort reporting (accounting for researcher time), improper cost accounting, and inflated facilities and administrative (F&A) costs.

We saw an example of this in July, when Continue reading Columbia has settled a fraud case for $9.5M. Here’s why that’s important.

Danish court dismisses charges against neuroscientist in appeal of fraud verdict

court-caseA Copenhagen court has cleared neuroscientist Milena Penkowa of the most serious charges against her after she appealed a 2015 verdict that she had faked data.

According to the CPH Post, the Eastern High Court in Copenhagen dismissed the case. Although the court acknowledged she had committed fraud, it declared it was not “serious forgery.”

On Facebook, Penkowa posted a message (according to the Facebook translation): Continue reading Danish court dismisses charges against neuroscientist in appeal of fraud verdict

Scientists investigated for misconduct lose appeal in suit against Harvard. Lawyers explain what it means.

Paul S. Thaler
Paul S. Thaler
Richard Goldstein
Richard Goldstein

Retraction Watch readers may recall the case of Piero Anversa and Annarosa Leri, both formerly of Harvard and the Brigham & Women’s Hospital in Boston. The pair — which has had their work subjected to a retraction, expression of concern, and correction — sued their former employers in 2014 for costing them job offers after the institutions notified journals, triggering notices. A judge dismissed the case a year ago, saying that Anversa and Leri had to try other administrative remedies before bringing suit.

But Anversa and Leri appealed, and last week, a court denied that appeal. (See the judge’s decision — which begins by quoting Ecclesiastes and includes the delicious word “gallimaufry” — here.) We spoke by email to two attorneys — Richard Goldstein, who represented the scientist in Bois v. HHS, the first case to overturn a funding ban by the Office of Research Integrity (ORI), and Paul Thaler, who has represented scientists involved in misconduct proceedings for more than 25 years — about the case, and what it could mean for similar lawsuits.

Retraction Watch: The decision seems to stop Anversa and Leri from continuing their suit against Harvard and the Brigham, but also acknowledges some of the scientists’ concerns as legitimate. How would you summarize the findings and their implications? Continue reading Scientists investigated for misconduct lose appeal in suit against Harvard. Lawyers explain what it means.